A AGILENT TECHNOLOGIES, INC. NYSE · United States

AGILENT TECHNOLOGIES, INC. (A) news

AGILENT TECHNOLOGIES, INC. is a public biotech or pharmaceutical company listed on NYSE under the ticker A, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest AGILENT TECHNOLOGIES, INC. news

We have not published a story on AGILENT TECHNOLOGIES, INC. yet. When there is news, it will appear here.

AGILENT TECHNOLOGIES, INC. annual financials

Line	FY ended Oct 31, 2025	FY ended Oct 31, 2024
Research and development	$455.0 million	$479.0 million
Net income (loss)	$1.30 billion	$1.29 billion
Cash from operations	$1.56 billion	$1.75 billion
Cash and equivalents	$1.79 billion	$1.33 billion

Latest balance sheet, Jul 31, 2026 (10-Q): cash and equivalents $1.76 billion.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about AGILENT TECHNOLOGIES, INC.

What is the ticker symbol of AGILENT TECHNOLOGIES, INC.?

AGILENT TECHNOLOGIES, INC. trades under the ticker A on NYSE.

Where is AGILENT TECHNOLOGIES, INC. listed?

AGILENT TECHNOLOGIES, INC. is listed on NYSE.

Which country or territory is AGILENT TECHNOLOGIES, INC. listed under?

Our directory records AGILENT TECHNOLOGIES, INC. under United States.

Does aibio.space cover AGILENT TECHNOLOGIES, INC.?

aibio.space lists AGILENT TECHNOLOGIES, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

Is AGILENT TECHNOLOGIES, INC. profitable?

AGILENT TECHNOLOGIES, INC. reported net income of $1.30 billion for the fiscal year ended Oct 31, 2025, and generated $1.56 billion of cash from operations, per its annual report to the SEC.

How much does AGILENT TECHNOLOGIES, INC. spend on research and development?

$455.0 million in the fiscal year ended Oct 31, 2025, per its annual report.

How much cash does AGILENT TECHNOLOGIES, INC. have?

$1.76 billion in cash at Jul 31, 2026, per its 10-Q.

Investor discussion: AGILENT TECHNOLOGIES, INC.

Members talk about AGILENT TECHNOLOGIES, INC. (A). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at AGILENT TECHNOLOGIES, INC., newest first. Each line links the filing it comes from.

Sep 1, 2026Mergers
Filed documents for a merger or acquisition. SEC Form S-4. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:A on TradingView.

Listing details

Company: AGILENT TECHNOLOGIES, INC.
Ticker: A
Listing: NYSE
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction